Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

54.84
Delayed Data
As of Apr 29
 -0.90 / -1.61%
Today’s Change
45.69
Today|||52-Week Range
61.70
+3.82%
Year-to-Date

Today’s Trading

Previous close55.74
Today’s open55.64
Day’s range54.56 - 55.64
Volume13,228,031
Average volume (3 months)10,584,434
Market cap$154.4B
Dividend yield3.36%
Data as of 4:01pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-61.67%
Earnings growth (this year)+3.48%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)-7.92%
P/E ratio35.1
Price/Sales3.87
Price/Book3.47

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc-3.05-0.37%
NVSNovartis-0.84-1.09%
BMYBristol-Myers Squibb-0.08-0.11%
SNYSanofi-1.75-4.08%
Data as of 4:03pm ET, 04/29/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)$0.85
Annual revenue (last year)$38.8B
Annual profit (last year)$4.4B
Net profit margin11.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts

Partner Offers

Search for Jobs